Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Oct, 2014 | Pages:
536 | Publisher: Global Markets Direct
Industry: Healthcare | Report Format: Electronic (PDF)
Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2014 Summary Global Markets Direct's, 'Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2014', provides an overview of the Chronic Obstructive Pulmonary Disease (COPD)'s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chronic Obstructive Pulmonary Disease (COPD), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chronic Obstructive Pulmonary Disease (COPD) and special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global therapeutic landscape of Chronic Obstructive Pulmonary Disease (COPD) - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Chronic Obstructive Pulmonary Disease (COPD) and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Chronic Obstructive Pulmonary Disease (COPD) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Chronic Obstructive Pulmonary Disease (COPD) pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Chronic Obstructive Pulmonary Disease (COPD) - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Chronic Obstructive Pulmonary Disease (COPD) pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table of Contents Table of Contents 2 Introduction 7 Chronic Obstructive Pulmonary Disease (COPD) Overview 8 Therapeutics Development 9 Chronic Obstructive Pulmonary Disease (COPD) - Therapeutics under Development by Companies 11 Chronic Obstructive Pulmonary Disease (COPD) - Therapeutics under Investigation by Universities/Institutes 20 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Products Glance 22 Chronic Obstructive Pulmonary Disease (COPD) - Products under Development by Companies 26 Chronic Obstructive Pulmonary Disease (COPD) - Products under Investigation by Universities/Institutes 39 Chronic Obstructive Pulmonary Disease (COPD) - Companies Involved in Therapeutics Development 40 Chronic Obstructive Pulmonary Disease (COPD) - Therapeutics Assessment 141 Drug Profiles 156 Chronic Obstructive Pulmonary Disease (COPD) - Recent Pipeline Updates 411 Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects 486 Chronic Obstructive Pulmonary Disease (COPD) - Discontinued Products 500 Chronic Obstructive Pulmonary Disease (COPD) - Product Development Milestones 503 Appendix 514
List of Tables Number of Products under Development for Chronic Obstructive Pulmonary Disease (COPD), H2 2014 30 Number of Products under Development for Chronic Obstructive Pulmonary Disease (COPD) - Comparative Analysis, H2 2014 31 Number of Products under Development by Companies, H2 2014 33 Number of Products under Development by Companies, H2 2014 (Contd..1) 34 Number of Products under Development by Companies, H2 2014 (Contd..2) 35 Number of Products under Development by Companies, H2 2014 (Contd..3) 36 Number of Products under Development by Companies, H2 2014 (Contd..4) 37 Number of Products under Development by Companies, H2 2014 (Contd..5) 38 Number of Products under Development by Companies, H2 2014 (Contd..6) 39 Number of Products under Development by Companies, H2 2014 (Contd..7) 40 Number of Products under Investigation by Universities/Institutes, H2 2014 42 Comparative Analysis by Late Stage Development, H2 2014 43 Comparative Analysis by Clinical Stage Development, H2 2014 44 Comparative Analysis by Early Stage Development, H2 2014 45 Comparative Analysis by Unknown Stage Development, H2 2014 46 Products under Development by Companies, H2 2014 47 Products under Development by Companies, H2 2014 (Contd..2) 49 Products under Development by Companies, H2 2014 (Contd..3) 50 Products under Development by Companies, H2 2014 (Contd..4) 51 Products under Development by Companies, H2 2014 (Contd..5) 52 Products under Development by Companies, H2 2014 (Contd..6) 53 Products under Development by Companies, H2 2014 (Contd..7) 54 Products under Development by Companies, H2 2014 (Contd..9) 56 Products under Development by Companies, H2 2014 (Contd..10) 57 Products under Development by Companies, H2 2014 (Contd..11) 58 Products under Development by Companies, H2 2014 (Contd..12) 59 Products under Investigation by Universities/Institutes, H2 2014 60 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Ache Laboratorios Farmaceuticos S/A, H2 2014 61 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Adamis Pharmaceuticals Corporation, H2 2014 62 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Advinus Therapeutics Ltd., H2 2014 63 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by AIM Therapeutics Inc., H2 2014 64 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Alba Therapeutics Corporation, H2 2014 65 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Alchemia Limited, H2 2014 66 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by AlgiPharma AS, H2 2014 67 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Almirall, S.A., H2 2014 68 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Amakem NV, H2 2014 69 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Ampio Pharmaceuticals, Inc., H2 2014 70 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Apellis Pharmaceuticals, Inc., H2 2014 71 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Aquinox Pharmaceuticals Inc., H2 2014 72 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Ario Pharma Ltd, H2 2014 73 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Asmacure Ltee, H2 2014 74 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Astellas Pharma Inc., H2 2014 75 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by AstraZeneca PLC, H2 2014 76 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Asubio Pharma Co., Ltd., H2 2014 77 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Axikin Pharmaceuticals, Inc., H2 2014 78 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Basilea Pharmaceutica AG, H2 2014 79 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Bioheart, Inc., H2 2014 80 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Biotie Therapies Corp., H2 2014 81 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Boehringer Ingelheim GmbH, H2 2014 82 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Carolus Therapeutics, Inc., H2 2014 83 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Cempra, Inc., H2 2014 84 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Chiesi Farmaceutici SpA, H2 2014 85 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Clarassance, Inc., H2 2014 86 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Concert Pharmaceuticals, Inc., H2 2014 87 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Corridor Pharmaceuticals Inc., H2 2014 88 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Cubist Pharmaceuticals, Inc., H2 2014 89 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Cytokinetics, Inc., H2 2014 90 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Daiichi Sankyo Company, Limited, H2 2014 91 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Domainex Ltd., H2 2014 92 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Dong Wha Pharma Co., Ltd., H2 2014 93 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Dynavax Technologies Corporation, H2 2014 94 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Edmond Pharma Srl, H2 2014 95 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Errant Gene Therapeutics, LLC, H2 2014 96 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Five Prime Therapeutics, Inc., H2 2014 97 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Foresee Pharmaceuticals, LLC, H2 2014 98 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Galapagos NV, H2 2014 99 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by GeneFrontier Corporation, H2 2014 100 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Gilead Sciences, Inc., H2 2014 101 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by GlaxoSmithKline plc, H2 2014 103 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by GlycoMar Limited, H2 2014 104 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Grifols, S.A., H2 2014 105 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by High Point Pharmaceuticals, LLC, H2 2014 106 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Hydra Biosciences, Inc., H2 2014 107 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by iCeutica, Inc., H2 2014 108 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Invion Limited, H2 2014 109 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Jiangsu Hansoh Pharmaceutical Co., Ltd., H2 2014 110 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Johnson & Johnson, H2 2014 111 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by KaloBios Pharmaceuticals, Inc., H2 2014 112 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Kissei Pharmaceutical Co., Ltd., H2 2014 113 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Kyowa Hakko Kirin Co., Ltd., H2 2014 114 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Laboratoires Pierre Fabre SA, H2 2014 115 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by LTT Bio-Pharma Co., Ltd., H2 2014 116 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Medestea Research & Production S.p.A., H2 2014 117 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Microbion Corporation, H2 2014 118 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by MSM Protein Technologies, Inc., H2 2014 119 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by N30 Pharmaceuticals, H2 2014 120 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Nostrum Pharmaceuticals, LLC, H2 2014 121 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Novabiotics Ltd, H2 2014 122 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Novartis AG, H2 2014 123 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Ockham Biotech Limited, H2 2014 124 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by OPKO Health, Inc., H2 2014 125 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Orion Oyj, H2 2014 126 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Otsuka Holdings Co., Ltd., H2 2014 127 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by P2D Bioscience, H2 2014 128 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Panmira Pharmaceuticals, LLC., H2 2014 129 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Peptinnovate Limited, H2 2014 130 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Pfizer Inc., H2 2014 131 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by PharmaLundensis AB, H2 2014 132 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Pharmaxis Limited, H2 2014 133 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Promedior, Inc., H2 2014 134 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Prosonix Ltd, H2 2014 135 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Pulmatrix, Inc., H2 2014 136 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Qu Biologics Inc., H2 2014 137 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Ranbaxy Laboratories Limited, H2 2014 138 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Re-Pharm Limited, H2 2014 139 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Respiratorius AB, H2 2014 140 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Rhizen Pharmaceuticals SA, H2 2014 141 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Rottapharm SpA, H2 2014 142 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by SelectX Pharmaceuticals, Inc., H2 2014 143 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Seoul Pharma Co., Ltd., H2 2014 144 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by SkyePharma PLC, H2 2014 145 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Sparsha Pharma International Pvt. Ltd., H2 2014 146 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Spring Bank Pharmaceuticals, Inc., H2 2014 147 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Stelic Institute & Co., H2 2014 148 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Stempeutics Research Private Limited, H2 2014 149 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by sterna biologicals Gmbh & Co KG, H2 2014 150 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Sucampo Pharmaceuticals, Inc., H2 2014 151 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Sunovion Pharmaceuticals Inc., H2 2014 152 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by SuppreMol GmbH, H2 2014 153 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Syntrix Biosystems, Inc., H2 2014 154 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Takeda Pharmaceutical Company Limited, H2 2014 155 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Teva Pharmaceutical Industries Limited, H2 2014 156 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Theraclone Sciences, Inc., H2 2014 157 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Torrent Pharmaceuticals Limited, H2 2014 158 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Verona Pharma Plc, H2 2014 159 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Yungjin Pharm Ind. Co., Ltd., H2 2014 160 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Zambon Company S.p.A., H2 2014 161 Assessment by Monotherapy Products, H2 2014 162 Assessment by Combination Products, H2 2014 163 Number of Products by Stage and Target, H2 2014 165 Number of Products by Stage and Mechanism of Action, H2 2014 170 Number of Products by Stage and Route of Administration, H2 2014 174 Number of Products by Stage and Molecule Type, H2 2014 176 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics - Recent Pipeline Updates, H2 2014 432 Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects, H2 2014 507 Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects (Contd..1), H2 2014 508 Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects (Contd..2), H2 2014 509 Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects (Contd..3), H2 2014 510 Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects (Contd..4), H2 2014 511 Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects (Contd..5), H2 2014 512 Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects (Contd..6), H2 2014 513 Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects (Contd..7), H2 2014 514 Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects (Contd..8), H2 2014 515 Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects (Contd..9), H2 2014 516 Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects (Contd..10), H2 2014 517 Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects (Contd..11), H2 2014 518 Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects (Contd..12), H2 2014 519 Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects (Contd..13), H2 2014 520 Chronic Obstructive Pulmonary Disease (COPD) - Discontinued Products, H2 2014 521
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
